TELMIVIB M 50METOPROLOL SUCCINATE 47.5mg. IP + METOPROLOL TARTRATE 50mg. IP + TELMISARTAN 40m...

Telmivib M 50 tablets combine metoprolol and telmisartan to lower raised blood pressure in adults with hypertension. Main uses: treatment of hypertension (high blood pressure) in adults, to lower blood pressure; lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, mainly strokes and myocardial infarctions; used as part of a wider cardiovascular risk management plan as advised by the doctor; many patients need more than one medicine to reach blood pressure goals; this tablet combines two such medicines.

Common side effects of Telmivib M 50 Tablet include tiredness; dizziness; slow heart rate (bradycardia); low blood pressure; shortness of breath; cold extremities. Get medical help at once if you notice worsening heart failure; worsening AV block; severe hypotension after starting therapy.

Each Telmivib M 50 tablet contains Metoprolol Succinate 47.5 mg + Metoprolol Tartrate 50 mg + Telmisartan 40 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Telmivib M 50 Tablet only as your doctor advises.

The MRP of Telmivib M 50 Tablet is ₹178 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹135.62 and the PTS is ₹122.06.

Each Telmivib M 50 tablet contains Metoprolol Succinate 47.5 mg + Metoprolol Tartrate 50 mg + Telmisartan 40 mg. It comes in a pack of 10x10 (Alu Alu).

Metoprolol succinate and metoprolol tartrate are two forms of metoprolol, a beta-1 selective blocker that slows the heart rate and lightens the work of the heart. Telmisartan is an angiotensin II receptor blocker that relaxes blood vessels by blocking the action of angiotensin II. Working together they help keep blood pressure at a lower level.

Must not be used during pregnancy; if pregnancy is detected it must be stopped as soon as possible. Must not be used in severe bradycardia, greater than first-degree heart block, sick sinus syndrome without a pacemaker, cardiogenic shock, decompensated heart failure, or if systolic blood pressure is below 100 mm Hg. Must not be used by anyone allergic to any of its components. Must not be given together with aliskiren in patients with diabetes; concomitant use with an ACE inhibitor should be avoided; beta-blockers should be avoided in bronchospastic disease such as asthma. Check with a doctor first if you have diabetes, liver or kidney problems, peripheral vascular disease, thyrotoxicosis or pheochromocytoma (an alpha-blocker must be started before metoprolol); do not stop the medicine suddenly.

Telmivib M 50 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.